Skip to main content
. 2024 Apr 8;29(2):169–174. doi: 10.5863/1551-6776-29.2.169

Table 1.

Risk Stratification and Intervention Recommendation Pathway Based on Reaction(s)

Risk Stratification Recommendation
No risk
  • Family history only

  • Tolerated the medication without reaction since initial documentation

  • Isolated GI upset

  • Isolated headache or fatigue

If family history only or has since tolerated
without reaction, remove allergy in EHR;
If isolated GI upset, headache, or fatigue only, update “allergy” to “intolerance” in EHR
Low risk
  • Itching only

  • Non-urticarial rash

  • Remote (>10 yr) history of non-anaphylactic IgE-­mediated reaction

  • Unknown reaction without features of IgE

Oral amoxicillin challenge for qualifying allergens
Moderate risk
  • Immediate (within 24 hr) development of urticarial rash

  • Other possible non-anaphylactic IgE-mediated reactions occurring within last 10 yr

Penicillin skin testing followed by oral
amoxicillin challenge for qualifying allergens
High risk
  • Immediate (within 1 hr) anaphylaxis requiring ­hospitalization

  • Steven-Johnson ­syndrome, toxic epidermal necrolysis, or drug rash with ­eosinophilia and systemic symptoms

  • Serum sickness

  • Acute interstitial nephritis or any organ involvement

  • Drug-induced anemia

  • Blistering rash

  • Joint pain

  • Drug-induced exfoliative dermatitis

  • Acute generalized exanthematous pustulosis

  • Vasculitis

  • Recurrent reaction with re-exposure

Avoid penicillin and recommend allergist
referral outpatient;
Inpatient penicillin skin testing may be considered for history of anaphylaxis >5 yr ago

EHR, electronic health record; GI, gastrointestinal; IgE, immunoglobulin E